Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WIRMS: Hookworm larvae in Multiple Sclerosis
NCT01470521Phase 2Completed
- Sponsor
- University of Nottingham
- Start
- Dec 2011
- Primary completion
- Jan 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in relapsing-remitting multiple sclerosis (RRMS) comparing Hookworm larvae with Placebo (2 arms). Primary endpoint: Cumulative number of new or enlarging Gd+ lesions at Month 9. Started Dec 2011; status: completed.
02
Drugs
Necator americanus larvae
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01470521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470521.